Three compounds (gallic acid, betulinic acid, and caffeic acid) had a significant inhibitory effect on lung squamous cell carcinoma via five biolabels (CPS1, CKM, CPT1B, COX5B, and COX4I1) [24]. The gene discussed is COX4I1; the disease is squamous cell lung carcinoma.